Advertisement

Topics

Real-life data supports efficacy and safety of biosimilar filgrastim

05:34 EDT 18 Aug 2017 | Generics and Biosimilars Initiative

Biosimilars of filgrastim are widely used in the prophylaxis of chemotherapy‐induced (CIN) and febrile neutropenia (FN). However, there are limited observational data on the use of granulocyte colony-stimulating factor (G‐CSF) in non‐Hodgkin’s lymphoma (NHL) and its aggressive subtypes including diffuse large B‐cell lymphoma (DLBCL).

Original Article: Real-life data supports efficacy and safety of biosimilar filgrastim

NEXT ARTICLE

More From BioPortfolio on "Real-life data supports efficacy and safety of biosimilar filgrastim"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open http://www.bioportfolio.com/channels?category_id=5 Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...